Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
14.70
+0.21 (1.45%)
Nov 21, 2024, 12:32 PM EST - Market open
Pediatrix Medical Group Market Cap
Pediatrix Medical Group has a market cap or net worth of $1.24 billion as of November 21, 2024. Its market cap has increased by 49.52% in one year.
Market Cap
1.24B
Enterprise Value
1.69B
1-Year Change
49.52%
Ranking
Category
Stock Price
$14.70
Market Cap Chart
Since December 1, 1998, Pediatrix Medical Group's market cap has increased from $834.00M to $1.24B, an increase of 48.98%. That is a compound annual growth rate of 1.55%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 20, 2024 | 1.24B | 59.25% |
Dec 29, 2023 | 781.40M | -36.70% |
Dec 30, 2022 | 1.23B | -47.53% |
Dec 31, 2021 | 2.35B | 11.99% |
Dec 31, 2020 | 2.10B | -10.33% |
Dec 31, 2019 | 2.34B | -20.61% |
Dec 31, 2018 | 2.95B | -41.04% |
Dec 29, 2017 | 5.00B | -19.82% |
Dec 30, 2016 | 6.24B | -7.38% |
Dec 31, 2015 | 6.74B | 1.51% |
Dec 31, 2014 | 6.64B | 23.64% |
Dec 31, 2013 | 5.37B | 35.52% |
Dec 31, 2012 | 3.96B | 12.50% |
Dec 30, 2011 | 3.52B | 9.76% |
Dec 31, 2010 | 3.21B | 14.73% |
Dec 31, 2009 | 2.80B | 93.36% |
Dec 31, 2008 | 1.45B | -56.14% |
Dec 31, 2007 | 3.30B | 39.08% |
Dec 29, 2006 | 2.37B | 8.41% |
Dec 30, 2005 | 2.19B | 52.82% |
Dec 31, 2004 | 1.43B | 10.48% |
Dec 31, 2003 | 1.30B | 28.17% |
Dec 31, 2002 | 1.01B | 21.90% |
Dec 31, 2001 | 829.40M | 117.46% |
Dec 29, 2000 | 381.40M | 249.91% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Novavax | 1.29B |
AdaptHealth | 1.27B |
Cassava Sciences | 1.26B |
Kura Oncology | 1.23B |
Enliven Therapeutics | 1.23B |
Maravai LifeSciences Holdings | 1.22B |
Innoviva | 1.19B |
Arcutis Biotherapeutics | 1.19B |